| ²é¿´: 435 | »Ø¸´: 4 | ||
[ÇóÖú]
ÇóÖú ÇóÖú
|
|
1199943-44-6 1354631-26-7 ËÖªµÀÕâÁ½¸ö¶«Î÷×öʲôÓÃµÄ |
» ²ÂÄãϲ»¶
26ÔÚÖ°É격¡ªÉúÎïÓëÒ½Ò©¡ª¿¹Ìå/ADCÒ©Îï·½Ïò£¬½Õ㻦£¬ÓÐÏîÄ¿£¬¿É´ø×Ê¡£
ÒѾÓÐ1È˻ظ´
26¿¼²©ÉêÇë ѧorר
ÒѾÓÐ15È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ228È˻ظ´
288·ÖÇóµ÷¼Á
ÒѾÓÐ0È˻ظ´
Ò»Ö¾Ô¸ËÕÖÝ´óѧ ÉúÎï¼¼ÊõÓ빤³Ì£¨086001£© ³õÊÔ323·Ö£¬Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
ÈýÄêʵÑéÊÒ¹¤×÷¾Àú£¬Ò»Ö¾Ô¸»ªÖÐũҵ´óѧ΢ÉúÎ×Ü·Ö288Çóµ÷¼Á
ÒѾÓÐ2È˻ظ´
070700Çóµ÷¼Á
ÒѾÓÐ1È˻ظ´
Çóµ÷¼Á×Ü·Ö327
ÒѾÓÐ1È˻ظ´
657562297
½ð³æ (СÓÐÃûÆø)
- DRDEPI: 1
- Ó¦Öú: 65 (³õÖÐÉú)
- ½ð±Ò: 497.1
- É¢½ð: 1000
- ºì»¨: 4
- Ìû×Ó: 281
- ÔÚÏß: 125.8Сʱ
- ³æºÅ: 1598651
- ×¢²á: 2012-02-04
- ÐÔ±ð: GG
- רҵ: Ò©ÎïÉè¼ÆÓëÒ©ÎïÐÅÏ¢
2Â¥2013-05-30 22:16:26
xukui
ľ³æ (ÕýʽдÊÖ)
Ò©Îﻯѧ
- Ó¦Öú: 6 (Ó×¶ùÔ°)
- ½ð±Ò: 6970
- É¢½ð: 50
- ºì»¨: 10
- Ìû×Ó: 657
- ÔÚÏß: 367.8Сʱ
- ³æºÅ: 252751
- ×¢²á: 2006-05-20
- ÐÔ±ð: GG
- רҵ: Ò©Îﻯѧ
3Â¥2013-05-31 08:14:03
lhs210042
гæ (СÓÐÃûÆø)
- Ó¦Öú: 36 (СѧÉú)
- ½ð±Ò: 403.8
- ºì»¨: 1
- Ìû×Ó: 146
- ÔÚÏß: 35.6Сʱ
- ³æºÅ: 1616044
- ×¢²á: 2012-02-14
- רҵ: Ó¦ÓÃÓлú»¯Ñ§
4Â¥2013-05-31 08:31:12
so0325
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 56 (³õÖÐÉú)
- ½ð±Ò: 1734.4
- ºì»¨: 3
- Ìû×Ó: 290
- ÔÚÏß: 120.8Сʱ
- ³æºÅ: 401234
- ×¢²á: 2007-06-13
- ÐÔ±ð: MM
- רҵ: ºÏ³ÉÒ©Îﻯѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
zsyysu: ½ð±Ò+1 2013-10-11 12:07:45
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
zsyysu: ½ð±Ò+1 2013-10-11 12:07:45
|
1354631-26-7: dyestuff intermediate; 1199943-44-6: is one kind of drug invented by Abott Laboratories,that acts as a selective full agonist of the peripheral cannabinoid receptor CB2, but which lower affinity for the peripheral CB1 receptor. |
5Â¥2013-05-31 09:21:59














»Ø¸´´ËÂ¥
ÕâÁ½¸öÊÇʲôºÅÄØ£¿
1-Îì»ù-1H-ßÅßá-3-»ù) (2,2,3,3-Ëļ׻ù»·±û»ù) ¼×ͪ)